inTEST Corporation
inTEST Corporation (INTT) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for inTEST Corporation (INTT), covering cash flow, earnings, and balance sheets.
inTEST Corporation (INTT) Income Statement & Financial Overview
Access detailed annual and quarterly income data for inTEST Corporation INTT financial performance.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $26.64M | $36.60M | $30.27M | $33.99M |
Cost of Revenue | $15.58M | $22.06M | $16.26M | $20.19M |
Gross Profit | $11.06M | $14.54M | $14.01M | $13.80M |
Gross Profit Ratio | $0.42 | $0.40 | $0.46 | $0.41 |
R&D Expenses | $2.45M | $2.17M | $2.18M | $2.22M |
SG&A Expenses | $10.36M | $10.29M | $11.34M | $11.24M |
Operating Expenses | $13.94M | $12.46M | $13.53M | $13.46M |
Total Costs & Expenses | $29.52M | $34.52M | $29.79M | $33.66M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $152000.00 | $234000.00 | $219000.00 | $253000.00 |
Depreciation & Amortization | $1.74M | $923000.00 | $1.66M | $1.52M |
EBITDA | -$896000.00 | $3.02M | $2.45M | $2.07M |
EBITDA Ratio | -$0.03 | $0.08 | $0.08 | $0.06 |
Operating Income | -$2.88M | $2.08M | $487000.00 | $336000.00 |
Operating Income Ratio | -$0.11 | $0.06 | $0.02 | $0.010 |
Other Income/Expenses (Net) | $92000.00 | -$277000.00 | $82000.00 | -$40000.00 |
Income Before Tax | -$2.79M | $1.80M | $569000.00 | $296000.00 |
Income Before Tax Ratio | -$0.10 | $0.05 | $0.02 | $0.009 |
Income Tax Expense | -$460000.00 | $298000.00 | $74000.00 | $66000.00 |
Net Income | -$2.33M | $1.50M | $495000.00 | $230000.00 |
Net Income Ratio | -$0.09 | $0.04 | $0.02 | $0.007 |
EPS | -$0.19 | $0.12 | $0.04 | $0.02 |
Diluted EPS | -$0.19 | $0.12 | $0.04 | $0.02 |
Weighted Avg Shares Outstanding | $12.18M | $12.16M | $12.19M | $12.23M |
Weighted Avg Shares Outstanding (Diluted) | $12.18M | $12.22M | $12.25M | $12.33M |
The company's financials show resilient growth, with revenue advancing from $33.99M in Q2 2024 to $26.64M in Q1 2025. Gross profit remained healthy with margins at 42% in Q1 2025 compared to 41% in Q2 2024. Operating income hit -$2.88M last quarter, sustaining a consistent -11% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$896000.00. Net income dropped to -$2.33M, while earnings per share reached -$0.19. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan